InsiderClue
Insiders · Profile

COLA MICHAEL F

Chief Executive Officer at Avalo Therapeutics · Director at Phathom Pharmaceuticals. Filing since 29 Oct 2019. CIK 0001188940

AVTX Avalo Therapeutics, Inc. Chief Executive Officer · 1 trade PHAT Phathom Pharmaceuticals, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
AVTX Avalo Therapeutics, Inc.
9 Jun 2020
Chief Executive Officer
Bought
100,000
$250.00K
132%
PHAT Phathom Pharmaceuticals, Inc.
29 Oct 2019
Director
Bought
9,798
$186.16K
opened
2 decisions on file.